| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/04/2011 | WO2011094363A2 Influenza virus compositions and methods for universal vaccines |
| 08/04/2011 | WO2011094357A2 Conjugates utilizing platform technology for stimulating immune response |
| 08/04/2011 | WO2011094285A1 Compositions and methods for treating, reducing, ameliorating, alleviating, or inhibiting progression of, pathogenic ocular neovascularization |
| 08/04/2011 | WO2011094259A2 Cd127 binding proteins |
| 08/04/2011 | WO2011093783A1 Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same |
| 08/04/2011 | WO2011093692A1 Method for newcastle disease virus propagation in a bioreactor |
| 08/04/2011 | WO2011093594A2 Vaccine vehicle including mycobacterial cell-wall skeleton and method for preparing vaccine using the same |
| 08/04/2011 | WO2011093097A1 Anti-dll3 antibody |
| 08/04/2011 | WO2011093083A1 Pharmaceutical composition for treatment or prevention of osteoarthritis, and method of production therefor |
| 08/04/2011 | WO2011093082A1 Use for production of therapeutic agent or prophylactic agent for osteoarthritis |
| 08/04/2011 | WO2011093081A1 Injectable solution containing therapeutic agent for osteoarthritis |
| 08/04/2011 | WO2011092715A2 Method for in-vivo binding of chromatin fragments |
| 08/04/2011 | WO2011092675A2 Molecular complex for targeting antigens towards cells comprising antigens and uses thereof for vaccination |
| 08/04/2011 | WO2011092593A2 Hiv-1 neutralizing antibodies and uses thereof |
| 08/04/2011 | WO2011092413A1 Adjuvant for the preparation of vaccine compositions intended for the prevention of coccidiosis |
| 08/04/2011 | WO2011092412A1 Use of a specific mineral oil for the production of a novel adjuvant |
| 08/04/2011 | WO2011092294A1 Extracellular ifi16 as therapeutic agents |
| 08/04/2011 | WO2011092253A1 Modified tuberculosis antigens |
| 08/04/2011 | WO2011092219A1 Biomarkers of cardiovascular disease including lrg |
| 08/04/2011 | WO2011092185A1 Salmonella vaccine |
| 08/04/2011 | WO2011092029A1 Vaccinia virus mutants containing the major genomic deletions of mva |
| 08/04/2011 | WO2011073630A3 Parasite vaccine |
| 08/04/2011 | WO2011067669A3 Hydrophilic filtration during manufacture of vaccine adjuvants |
| 08/04/2011 | WO2011060379A3 (poly)-glycerolphosphate-based anti-gram positive bacterial vaccine |
| 08/04/2011 | WO2011054011A3 Foot and mouth disease virus (fmdv) consensus proteins, coding sequences therefor and vaccines made therefrom |
| 08/04/2011 | WO2011050106A3 Anti-cd3 antibody dosing in autoimmune disease |
| 08/04/2011 | WO2011041613A3 Combination immunotherapy for the treatment of cancer |
| 08/04/2011 | WO2011036564A3 Hyperblebbing shigella strains |
| 08/04/2011 | WO2011022725A3 Mimotopes of hiv and uses thereof |
| 08/04/2011 | US20110191915 Influenza virus immunizing epitope |
| 08/04/2011 | US20110191875 Compositions and methods for making androstenediones |
| 08/04/2011 | US20110191872 Method for the humanization of antibodies and humanized antibodies thereby obtained |
| 08/04/2011 | US20110191866 Methods of making monoclonal antibodies using fusion-peptide epitope adoptive transfer (f-peat) technology |
| 08/04/2011 | US20110191865 Novel Gene Disruptions, Compositions and Methods Relating Thereto |
| 08/04/2011 | US20110190224 Non-Viral Delivery of Compounds to Mitochondria |
| 08/04/2011 | US20110190144 Novel compositions and methods for the treatment of psoriasis |
| 08/04/2011 | US20110189652 Viral variants with altered susceptability to nucloeside analogs and uses thereof |
| 08/04/2011 | US20110189651 Method and Device for Detecting Feline Immunodeficiency Virus |
| 08/04/2011 | US20110189299 Pharmaceutical composition containing surface-coated microparticles |
| 08/04/2011 | US20110189267 MULTIPLE CpG OLIGODEOXYNUCLEOTIDE AND THEIR USE TO INDUCE AN IMMUNE RESPONSE |
| 08/04/2011 | US20110189238 Use of a soluble form of hla-g in the treatment of abnormal b-lymphocyte proliferation |
| 08/04/2011 | US20110189236 Methods and Compositions for the Display of Polypeptides on the Pili of Gram-Positive Bacteria |
| 08/04/2011 | US20110189235 Adipogenic Adenoviruses As A Biomarker For Disease |
| 08/04/2011 | US20110189234 Adenovirus particles having a chimeric adenovirus spike protein, use thereof and methods for producing such particles |
| 08/04/2011 | US20110189233 Recombinant Varicella-Zoster Virus |
| 08/04/2011 | US20110189232 RECOMBINANT HUMAN PARAINFLUENZA TYPE 1 VIRUSES (HPIV1s) CONTAINING MUTATIONS IN OR DELETION OF THE C PROTEIN ARE ATTENUATED IN AFRICAN GREEN MONKEYS AND IN CILIATED HUMAN AIRWAY EPITHELIAL CELLS AND ARE POTENTIAL VACCINE CANDIDATES FOR HPIV1 |
| 08/04/2011 | US20110189231 Compositions Comprising Salmonella Porins and Uses Thereof as Adjuvants and Vaccines |
| 08/04/2011 | US20110189230 Vaccination with multiple clades of h5 influenza a virus |
| 08/04/2011 | US20110189229 Vaccine against hpv |
| 08/04/2011 | US20110189228 Production of Heterologous Polypeptides in Microalgae, Microalgal Extracellular Bodies, Compositions, and Methods of Making and Uses Thereof |
| 08/04/2011 | US20110189227 Porcine circovirus type 2 and use thereof |
| 08/04/2011 | US20110189226 Immunization Compositions and Methods |
| 08/04/2011 | US20110189225 Attenuated bacteria useful in vaccines |
| 08/04/2011 | US20110189224 Pestivirus replicons providing an rna-based viral vector system |
| 08/04/2011 | US20110189223 Vaccine |
| 08/04/2011 | US20110189219 Sialic acid to support the immune system in the elderly |
| 08/04/2011 | US20110189218 Plasmodium vivax hybrid circumsporozoite protein and vaccine |
| 08/04/2011 | US20110189217 Methods and materials for producing immune responses against polypeptides involved in antibiotic resistance |
| 08/04/2011 | US20110189216 Compositions and Methods for the Treatment and Prophylaxis of Multiple Strains and Subtypes of HIV-1 |
| 08/04/2011 | US20110189215 Vaccine Comprising Protein NMB0964 From Neisseria Meningitidis |
| 08/04/2011 | US20110189214 Cdca1 epitope peptides and vaccines containing the same |
| 08/04/2011 | US20110189213 Mybl2 epitope peptides and vaccines containing the same |
| 08/04/2011 | US20110189212 Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders |
| 08/04/2011 | US20110189210 Method of inhibiting remnant lipoprotein production |
| 08/04/2011 | US20110189209 Fold-back diabody diphtheria toxin immunotoxin and methods of use |
| 08/04/2011 | US20110189208 Tb vaccine |
| 08/04/2011 | US20110189207 Methods for soluble zalpha11 cytokine receptors |
| 08/04/2011 | US20110189206 Antibody Targeting Through a Modular Recognition Domain |
| 08/04/2011 | US20110189205 Methods of treating cancer using an agent that modulates activity of the calcitonin-gene related peptide ("cgrp") receptor |
| 08/04/2011 | US20110189204 Treatment of Disease with Proteasone Inhibitors |
| 08/04/2011 | US20110189203 Immunoglobulin constructs |
| 08/04/2011 | US20110189202 Compositions comprising soluble cd84 or anti-cd84 antibodies and methods for diagnosing and treating b-cll |
| 08/04/2011 | US20110189201 Modulation of bone development |
| 08/04/2011 | US20110189200 Methods of treating autoimmune diseases with dll4 antagonists |
| 08/04/2011 | US20110189199 Methods for p2ry5 mediated regulation of hair growth and mutants thereof |
| 08/04/2011 | US20110189198 Compositions and Methods for Diagnosing and Treating an Inflammation |
| 08/04/2011 | US20110189197 Antibodies Against Protective Antigen |
| 08/04/2011 | US20110189196 Metal-citrate transporter antigen from streptomyces coelicolor and uses thereof |
| 08/04/2011 | US20110189195 Method for controlling cancer metastasis or cancer cell migration by modulating the cellular level of lysyl trna synthetase |
| 08/04/2011 | US20110189194 Use of cd95 inhibitors for the treatment of inflammatory disorders |
| 08/04/2011 | US20110189193 Cell lines and host nucleic acid sequences related to infectious disease |
| 08/04/2011 | US20110189192 Novel compounds that are erk inhibitors |
| 08/04/2011 | US20110189191 Methods and Compositions for Treating Conditions of the Eye |
| 08/04/2011 | US20110189190 Anti-hepcidin-25 selective antibodies and uses thereof |
| 08/04/2011 | US20110189189 Combination of cd137 antibody and ctla-4 antibody for the treatment of proliferative diseases |
| 08/04/2011 | US20110189188 Novel gp96 derived peptides |
| 08/04/2011 | US20110189187 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 08/04/2011 | US20110189186 Affecting bone related conditions using cd68 blocking agents |
| 08/04/2011 | US20110189185 Method for Predicting Responsiveness to a Treatment With an Anti-HER2 Antibody |
| 08/04/2011 | US20110189184 Modulation of neural stem cells and neural progenitor cells |
| 08/04/2011 | US20110189183 Antibodies against candida, collections thereof and methods of use |
| 08/04/2011 | US20110189182 Proteolytically cleavable fusion proteins with high molar specific activity |
| 08/04/2011 | US20110189181 Use of agents derived from CEACAM1 for the treatment of inflammatory diseases |
| 08/04/2011 | US20110189180 Antigenic compositions and use of same in the targeted delivery of nucleic acids |
| 08/04/2011 | US20110189179 Identification of Tumor-Associated Antigens for Diagnosis and Therapy |
| 08/04/2011 | US20110189178 Immunoprotection of Therapeutic Moieties Using Enhanced Fc Regions |
| 08/04/2011 | US20110189177 Antibodies to vla-1 |
| 08/04/2011 | US20110189176 Methods of treating diseases with dll4 antagonists |
| 08/04/2011 | US20110189175 Chronic lymphocytic leukemia prognosis and treatment |
| 08/04/2011 | US20110189174 Compositions and methods for treating, reducing, ameliorating, alleviating, or inhibiting progression of, pathogenic ocular neovascularization |